NVCR Research and Charts

NVCR - NovoCure Ltd (Healthcare: Medical Instruments & Supplies)

Projected Earnings Date: 2025-10-23 (Delayed quote data 2025-09-10)

Last 12.21	Change ⇓ -0.45 (-3.55%)	Volume 1,482,374
	Open 12.54	High 12.75	Low 11.98

8EMA (Daily) 12.29	40EMA (Daily) 12.94	50EMA (Daily) 13.36	STO (Daily) 51.972	MACD Hist (Daily) 0.330
8EMA (Weekly) 12.789	40EMA (Weekly) 16.88	50EMA (Weekly) 17.71	STO (Weekly) 14.718	MACD Hist (Weekly) -0.409


Company Profile
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves commercial-stage oncology operations involving therapies to cure critical tumors. Its pipeline consists of Ovarian Cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer, and Brain Metastasis. NovoCure derives its major revenues in the United States.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.